Global Connected Injectable Drug Delivery Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 150398
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 135
  • list Medical Devices

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition.

Scope of the Report:

Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of the Connected injectable drug delivery devices.

The worldwide market for Connected Injectable Drug Delivery Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Connected Injectable Drug Delivery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Phillips-Medisize

West Pharmaceutical Services

Biocorp

Aterica

Unilife

Propeller Health

Haselmeier

SHL

Becton Dickinson

Baxter International

Scandinavian Health

Ypsomed

Terumo Medical

Schott

Owen Mumford

Antares Pharma

Zogenix

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Conventional

Self-Injection

Others

Market Segment by Applications, can be divided into

Diabetes

Cardiovascular Diseases

Autoimmune Diseases

Hormones Replacement

Neurology

Addiction

Respiratory Diseases

Others

There are 15 Chapters to deeply display the global Connected Injectable Drug Delivery Devices market.

Chapter 1, to describe Connected Injectable Drug Delivery Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Connected Injectable Drug Delivery Devices, with sales, revenue, and price of Connected Injectable Drug Delivery Devices, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Connected Injectable Drug Delivery Devices, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Connected Injectable Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Connected Injectable Drug Delivery Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Connected Injectable Drug Delivery Devices Introduction

1.2 Market Analysis by Type

1.2.1 Conventional

1.2.2 Self-Injection

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Diabetes

1.3.2 Cardiovascular Diseases

1.3.3 Autoimmune Diseases

1.3.4 Hormones Replacement

1.3.5 Neurology

1.3.6 Addiction

1.3.7 Respiratory Diseases

1.3.8 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Phillips-Medisize

2.1.1 Business Overview

2.1.2 Connected Injectable Drug Delivery Devices Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 West Pharmaceutical Services

2.2.1 Business Overview

2.2.2 Connected Injectable Drug Delivery Devices Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biocorp

2.3.1 Business Overview

2.3.2 Connected Injectable Drug Delivery Devices Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Aterica

2.4.1 Business Overview

2.4.2 Connected Injectable Drug Delivery Devices Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Unilife

2.5.1 Business Overview

2.5.2 Connected Injectable Drug Delivery Devices Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Propeller Health

2.6.1 Business Overview

2.6.2 Connected Injectable Drug Delivery Devices Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Haselmeier

2.7.1 Business Overview

2.7.2 Connected Injectable Drug Delivery Devices Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 SHL

2.8.1 Business Overview

2.8.2 Connected Injectable Drug Delivery Devices Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Becton Dickinson

2.9.1 Business Overview

2.9.2 Connected Injectable Drug Delivery Devices Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Baxter International

2.10.1 Business Overview

2.10.2 Connected Injectable Drug Delivery Devices Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Scandinavian Health

2.11.1 Business Overview

2.11.2 Connected Injectable Drug Delivery Devices Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Ypsomed

2.12.1 Business Overview

2.12.2 Connected Injectable Drug Delivery Devices Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Terumo Medical

2.13.1 Business Overview

2.13.2 Connected Injectable Drug Delivery Devices Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Schott

2.14.1 Business Overview

2.14.2 Connected Injectable Drug Delivery Devices Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Owen Mumford

2.15.1 Business Overview

2.15.2 Connected Injectable Drug Delivery Devices Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Antares Pharma

2.16.1 Business Overview

2.16.2 Connected Injectable Drug Delivery Devices Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Zogenix

2.17.1 Business Overview

2.17.2 Connected Injectable Drug Delivery Devices Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Connected Injectable Drug Delivery Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Connected Injectable Drug Delivery Devices Manufacturer Market Share in 2017

3.3.2 Top 6 Connected Injectable Drug Delivery Devices Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Connected Injectable Drug Delivery Devices Market Analysis by Regions

4.1 Global Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Regions

4.1.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Regions (2013-2018)

4.1.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Regions (2013-2018)

4.2 North America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

4.3 Europe Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

4.5 South America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

5 North America Connected Injectable Drug Delivery Devices by Countries

5.1 North America Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries

5.1.1 North America Connected Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)

5.1.2 North America Connected Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)

5.2 United States Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

5.3 Canada Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

5.4 Mexico Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

6 Europe Connected Injectable Drug Delivery Devices by Countries

6.1 Europe Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries

6.1.1 Europe Connected Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Connected Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)

6.2 Germany Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

6.3 UK Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

6.4 France Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

6.5 Russia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

6.6 Italy Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

7 Asia-Pacific Connected Injectable Drug Delivery Devices by Countries

7.1 Asia-Pacific Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Connected Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Connected Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)

7.2 China Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

7.3 Japan Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

7.4 Korea Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

7.5 India Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

8 South America Connected Injectable Drug Delivery Devices by Countries

8.1 South America Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries

8.1.1 South America Connected Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)

8.1.2 South America Connected Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

8.3 Argentina Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

8.4 Colombia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

9 Middle East and Africa Connected Injectable Drug Delivery Devices by Countries

9.1 Middle East and Africa Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Connected Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Connected Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

9.3 UAE Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

9.4 Egypt Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

9.5 Nigeria Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

9.6 South Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)

10 Global Connected Injectable Drug Delivery Devices Market Segment by Type

10.1 Global Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Type (2013-2018)

10.1.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Type (2013-2018)

10.2 Conventional Sales Growth and Price

10.2.1 Global Conventional Sales Growth (2013-2018)

10.2.2 Global Conventional Price (2013-2018)

10.3 Self-Injection Sales Growth and Price

10.3.1 Global Self-Injection Sales Growth (2013-2018)

10.3.2 Global Self-Injection Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Connected Injectable Drug Delivery Devices Market Segment by Application

11.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2013-2018)

11.2 Diabetes Sales Growth (2013-2018)

11.3 Cardiovascular Diseases Sales Growth (2013-2018)

11.4 Autoimmune Diseases Sales Growth (2013-2018)

11.5 Hormones Replacement Sales Growth (2013-2018)

11.6 Neurology Sales Growth (2013-2018)

11.7 Addiction Sales Growth (2013-2018)

11.8 Respiratory Diseases Sales Growth (2013-2018)

11.9 Others Sales Growth (2013-2018)

12 Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.1 Global Connected Injectable Drug Delivery Devices Sales, Revenue and Growth Rate (2018-2023)

12.2 Connected Injectable Drug Delivery Devices Market Forecast by Regions (2018-2023)

12.2.1 North America Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.2.2 Europe Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.2.3 Asia-Pacific Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.2.4 South America Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.2.5 Middle East and Africa Connected Injectable Drug Delivery Devices Market Forecast (2018-2023)

12.3 Connected Injectable Drug Delivery Devices Market Forecast by Type (2018-2023)

12.3.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2018-2023)

12.3.2 Global Connected Injectable Drug Delivery Devices Market Share Forecast by Type (2018-2023)

12.4 Connected Injectable Drug Delivery Devices Market Forecast by Application (2018-2023)

12.4.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2018-2023)

12.4.2 Global Connected Injectable Drug Delivery Devices Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Connected Injectable Drug Delivery Devices Picture

Table Product Specifications of Connected Injectable Drug Delivery Devices

Figure Global Sales Market Share of Con

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery